Oasmia Pharmaceutical AB Stock NORDIC GROWTH MARKET
Equities
OASM
SE0000722365
Pharmaceuticals
Sales 2021 | 28.87M 0 | Sales 2022 | 3.04M 0 | Capitalization | 234M 0 |
---|---|---|---|---|---|
Net income 2021 | -133M - | Net income 2022 | -357M - | EV / Sales 2021 | 37.7 x |
Net cash position 2021 | 86.84M 0 | Net cash position 2022 | 134M 0 | EV / Sales 2022 | 32.6 x |
P/E ratio 2021 |
-8.86
x | P/E ratio 2022 |
-0.6
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 61.42% |
Latest transcript on Oasmia Pharmaceutical AB
Managers | Title | Age | Since |
---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 66 | 23-01-22 |
Robert Maiorana
DFI | Director of Finance/CFO | 64 | 20-11-30 |
Heidi Ramstad
CTO | Chief Tech/Sci/R&D Officer | 55 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 44 | 19-03-18 | |
Hege Hellstrom
BRD | Director/Board Member | 59 | 19-09-25 |
Pål Ryfors
BRD | Director/Board Member | 41 | 22-05-24 |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |